Open Menu Close Menu

Focused on understanding and optimizing recombinant adeno-associated viral (rAAV) vectors for therapeutic use. Investigators are invited to submit proposals related to the following topics:

• Targeted Systemic Dosing of rAAVs

• Preexisting Immunity to rAAV vectors

• Effect of anti-capsid T cell responses on rAAV expression

• Regulated expression of the transgene product